• Tue, August 6, 2024

by: WOPRAI

Benjamin Theurer Maintained (TSN) at Buy with Increased Target to $72 on, Aug 6th, 2024

by: WOPRAI

Kenneth Goldman Maintained (TSN) at Hold with Increased Target to $63 on, Aug 6th, 2024

by: WOPRAI

Mehdi Hosseini Maintained (TSM) at Buy and Held Target at $250 on, Aug 6th, 2024

by: WOPRAI

Ruben Roy Maintained (VIAV) at Strong Buy with Decreased Target to $11 on, Aug 6th, 2024

by: WOPRAI

John Kernan Maintained (VFC) at Hold with Increased Target to $16 on, Aug 6th, 2024

by: WOPRAI

Chris Woronka Maintained (VAC) at Strong Buy with Decreased Target to $95 on, Aug 6th, 2024

by: WOPRAI

Eric Hagen Maintained (UWMC) at Strong Buy with Increased Target to $10 on, Aug 6th, 2024

by: WOPRAI

Heiko Ihle Maintained (UUUU) at Strong Buy and Held Target at $11 on, Aug 6th, 2024

by: WOPRAI

Blair Abernethy Maintained (CDNS) at Hold and Held Target at $280 on, Aug 6th, 2024

by: WOPRAI

Michael Leithead Maintained (CE) at Hold with Decreased Target to $151 on, Aug 6th, 2024

by: WOPRAI

Alexander Goldfarb Maintained (ALX) at Sell with Decreased Target to $125 on, Aug 6th, 2024

by: WOPRAI

Betty Jiang Maintained (VNOM) at Buy with Increased Target to $47 on, Aug 6th, 2024

by: WOPRAI

Youssef Squali Maintained (VMEO) at Strong Buy with Increased Target to $7 on, Aug 6th, 2024

by: WOPRAI

Thomas Champion Maintained (VMEO) at Hold with Increased Target to $5 on, Aug 6th, 2024

by: WOPRAI

James Faucette Maintained (VRRM) at Hold with Increased Target to $27 on, Aug 6th, 2024

by: WOPRAI

Rommel Dionisio Downgraded (VSTO) to Hold and Held Target at $40 on, Aug 6th, 2024

by: WOPRAI

Eric Beaumont Maintained (WEC) at Sell with Increased Target to $86 on, Aug 6th, 2024

by: WOPRAI

Chris Dankert Maintained (WCC) at Strong Buy with Decreased Target to $190 on, Aug 6th, 2024

by: WOPRAI

Russell Gunther Maintained (WSBC) at Hold with Increased Target to $34 on, Aug 6th, 2024

by: WOPRAI

Chris Pierce Maintained (TRUE) at Strong Buy with Decreased Target to $3.75 on, Aug 6th, 2024

by: WOPRAI

Michael Leithead Maintained (TROX) at Buy with Decreased Target to $19 on, Aug 6th, 2024

by: WOPRAI

Stephen Gengaro Maintained (TS) at Strong Buy with Decreased Target to $37 on, Aug 6th, 2024

by: WOPRAI

Andrew Strelzik Maintained (TSN) at Hold with Increased Target to $60 on, Aug 6th, 2024

by: WOPRAI

Mark Zgutowicz Reiterated (SNAP) at Hold on, Aug 6th, 2024

by: WOPRAI

Anupam Rama Maintained (SNDX) at Buy with Decreased Target to $33 on, Aug 6th, 2024

by: WOPRAI

Steve Sakwa Maintained (SPG) at Hold with Increased Target to $155 on, Aug 6th, 2024

by: WOPRAI

Simon Yarmak Maintained (SPG) at Strong Buy with Increased Target to $158 on, Aug 6th, 2024

by: WOPRAI

Eric Luebchow Maintained (DBRG) at Buy with Decreased Target to $18 on, Aug 6th, 2024

by: WOPRAI

Walter Spracklin Reiterated (CSX) at Hold and Held Target at $36 on, Aug 6th, 2024

by: WOPRAI

Fadi Chamoun Reiterated (CSX) at Buy and Held Target at $40 on, Aug 6th, 2024

by: WOPRAI

Brian Ossenbeck Maintained (CSX) at Buy with Increased Target to $42 on, Aug 6th, 2024

by: WOPRAI

Daniel Imbro Reiterated (CSX) at Buy and Held Target at $42 on, Aug 6th, 2024

by: WOPRAI

Ryan MacDonald Reiterated (CHGG) at Hold on, Aug 6th, 2024

by: WOPRAI

Arvind Ramnani Maintained (CHGG) at Sell with Decreased Target to $2 on, Aug 6th, 2024

by: WOPRAI

Mike Grondahl Maintained (CHGG) at Hold with Decreased Target to $6 on, Aug 6th, 2024

by: WOPRAI

Josh Baer Maintained (CHGG) at Hold with Decreased Target to $3 on, Aug 6th, 2024

by: WOPRAI

Eric Sheridan Upgraded (CHGG) to Hold and Decreased Target to $3.75 on, Aug 6th, 2024

by: WOPRAI

Etzer Darout Reiterated (CCCC) at Buy and Held Target at $20 on, Aug 6th, 2024

by: WOPRAI

Clarke Jeffries Upgraded (CDNS) to Buy and Held Target at $318 on, Aug 6th, 2024

by: WOPRAI

Shagun Singh Reiterated (TFX) at Buy and Held Target at $260 on, Aug 6th, 2024

by: WOPRAI

Edward White Reiterated (TGTX) at Strong Buy and Held Target at $49 on, Aug 6th, 2024

by: WOPRAI

Grace Carter Maintained (THG) at Hold with Decreased Target to $158 on, Aug 6th, 2024

by: WOPRAI

Matthew Smith Maintained (THS) at Hold with Increased Target to $41 on, Aug 6th, 2024

by: WOPRAI

Andrew Lazar Maintained (THS) at Hold with Increased Target to $39 on, Aug 6th, 2024

by: WOPRAI

Daniel Chan Downgraded (TIXT) to Hold and Decreased Target to $3.75 on, Aug 6th, 2024

by: WOPRAI

Bernie McTernan Reiterated (SSTK) at Strong Buy and Held Target at $65 on, Aug 6th, 2024

by: WOPRAI

Raghuram Selvaraju Reiterated (SPRO) at Strong Buy and Held Target at $7 on, Aug 6th, 2024

by: WOPRAI

Louise Chen Reiterated (SPRO) at Buy on, Aug 6th, 2024

Gena Wang Maintained (BCRX) at Hold with Increased Target to $7 on, Aug 6th, 2024

Gena Wang of Barclays, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold with Increased Target from $6 to $7 on, Aug 6th, 2024.

Gena has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Gena's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gena

  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $12 on, Tuesday, May 7th, 2024